|
In association with Mark Andrews,
BVM&S CertEP MRCVS, of Equine Science Update we are pleased
to provide the latest Equine Veterinary
Information
___________________________________________________
STRANGLES
Strangles is a contagious disease of
horses caused by the bacterium Streptococcus equi. Typical
signs include fever, loss of appetite, soft cough, purulent nasal
discharge and swollen lymph nodes of the face, which may often
abscessate and burst.
The swollen glands can restrict the airways - hence the name
"Strangles". In some cases, however, the disease may be very mild,
causing only slight nasal discharge without a raised temperature or
swollen glands. A carrier state without any obvious clinical signs
is also possible.
Horses of any age can be affected.
Younger animals (up to 5 years of age) are more often affected as
they have had less opportunity to develop
resistance.
The disease occurs
throughout the world and causes heavy economic loss in terms of the
cost of treatment, quarantine measures and occasionally the death of
affected animals. It is one of the most frequently diagnosed
infectious diseases of horses.
What causes
Strangles?
Streptococcus
equi is a
gram-postive bacterium, classified as Lancefield group C. It is not
a normal inhabitant of the upper airway of the horse, and does not
require prior infection with viruses to allow it to become
established and cause
disease.
There are two features of the organism
that contribute to its ability to cause
disease:
·
It is
surrounded by a capsule of hyaluronate, which has a strong
negative charge that appears to repell phagocytic cells (such as
neutrophils - one of the white blood cells). Hyaluronate is also
widepread throughout the body and its presence in the bacterium is
likely to help "disguise" it from the body's defence
mechanisms.
·
M-protein-
a component of the cell wall - enables the organism to adhere to
the epithelial cells of the nose and throat. It also protects the
bacterium from digestion by phagocytes.
The
severity of cases of strangles can vary. This may be because of
differences in immunity in the animal or different strains of the
bacteria.
In one group of
outbreaks, nearly a quarter of the S equi isolated lacked 20%
of the surface M-protein but were still able to causestrangles.
1
What are the
signs of strangles?
The
incubation period may be as short as 3 days or as long as 14 days.
The first sign may be fever
and a clear nasal discharge, which soon becomes purulent.
Swelling develops in lymph nodes of the head . The swelling may be so severe that the
horse has difficulty breathing. The affected lymph nodes usually
take 7 - 10 days to rupture.
In uncomplicated cases, the disease usually runs its course
in about 3 weeks.
Infection
is usually restricted to the head and neck and most horses recover
uneventfully. In up to 8% of cases, it may spread to other organs,
when it is known as
"bastard strangles", and can be fatal. Abscesses can occur anywhere
in the body, but are most often found in the lungs, abdominal lymph
nodes, liver, kidney, spleen and brain.
Another
complication which is usually fatal, but less common, is
"purpura
haemorrhagica". This is an immune-complex reaction to the
streptococcal antigen. Affected horses are depressed, and have
marked swelling of the legs and belly. They may bleed into the gums
and other organs such as the lungs.
Other
complications that have been reported include laryngeal paralysis,
infection of the heart (endocarditis, myocarditis) and
brochopneumonia.
How does it spread?
The most
important way strangles spreads is by direct contact between
infected and susceptible animals. This requires fairly close contact
between the horses.
Indirect
transmission is also common. S. equi will live for long
periods in shared water sources. As a result, the disease can spread
quickly in grazing animals sharing the water supply. The infection
can also spread on tack or handlers and their clothes. Particular
care should be taken with sleeves and other areas likely to come
into contact with the horse's face. The ease with which the disease
spreads through groups of animals depends largely on management
practices.
The
incubation period of strangles is usually less than 14 days.
However, the interval between new cases in an outbreak can be far
longer - up to 3 weeks or more - because infected horses can excrete
S. equi for long periods
after clinical signs have disappeared.
Strangles
can appear without the introduction of obviously sick
horses. There is
increasing evidence that carrier horses play an important role in
the spread of infection to susceptible animals. A recent study2 found that 15 / 22 outbreaks
(68%) produced at least one horse from which S equi could be isolated more than
4 weeks after the disappearance of clinical signs. The guttural
pouches are the main site of S. equi colonisation.
Carrier animals may remain a potential source of infection for a
considerable time. An
earlier investigation3 found that some horses
continued to harbour S.
equi for many months after signs had gone. One horse remained
infected for over three years.
Carriers are often released into a
susceptible population in the belief that they no longer present a
risk. So, many outbreaks of strangles occur after new animals, which
are unknown carriers, are introduced into groups. According to
Richard Newton of the Animal Health Trust in Newmarket, "People
can`t rely on the fact that horses just get over strangles and no
longer pose an infectious threat after a particular period of time.
This is a concept that veterinarians are only just coming to terms
with, and so it may be quite new to most horse
owners.
How is it diagnosed?
The
clinical signs are characteristic. A horse with a swollen throat and a thick
yellow purulent discharge almost certainly has strangles. The
diagnosis should be confirmed by culturing pus from abscessated
lymph nodes, nasal discharge or throat swabs.
"Nasopharyngeal"
swabs, taken from the back of the nose and throat, are most likely to detect the
organism . Special swabs with extra long shafts and absorbent heads
are available from the Animmal Health Trust.
All confirmed cases of
S. equi infection, in
Thoroughbreds or animals in contact with Thoroughbred horses should
be notified to the Thoroughbred Breeders' Association.Cases in
non-Throroughbreds should be reported to the British Horse
Society.
Identification of carrier animals
Animals carrying S. equi can be difficult to
detect and a negative result from bacteriological culture of a
single nasopharyngeal swab does not prove absence of infection.
Three consecutive swabs over a 2-week period greatly increase the
chance of detecting a carrier, particularly if the horse has only
recently recovered from the disease. Established carriers, however,
can go undetected by culture of repeated nasopharyngeal swabs for
2-3 months.
Researchers at the Animal Health Trust
has developed a PCR test to detect the DNA of S. equi.4 Polymerase chain
reaction (PCR ) is a very sensitive technique. It can detect an
individual molecule of target DNA, and so is able to identify a single organism. PCR in
conjunction with culture is much more sensitive than culture of
swabs alone.
The PCR test on nasopharyngeal
swabs is most useful as a screening test to indicate which horses
warrant further investigation. The next step in detecting
carriers is to examine the guttural pouches. Most carrier animals show signs of disease in the
guttural pouches - either purulent discharge or "chondroids".
("Chondroids" are hard dried aggregates of purulent material.) S. equi can be cultured from
washings taken from the pouches.
How is strangles treated?
1 Treatment of individual
animals
Strangles is difficult to treat
effectively because antibiotics do not penetrate the centre of an
abscess where there is no blood supply. However, resistance to
antibiotics commonly used against S equi is very rare, and so
early treatment with antibiotics may be helpful if lymph nodes have
not become enlarged. Each case should be assessed
individually.
·
In the early stages of the disease, before abscesses have
started
forming, penicillin
is very effective at killing the bacteria responsible.
·
Once an
abscess has formed it
is best to allow the abseces to burst. Antibiotics at this stage
tend to "damp down" the infection, but not eradicate it
completely, so it may flare up again once treatment stops.
Fomenting the abscessed lymph nodes with hot cloths or compresses
may encourage them to burst and
drain.
Most
cases recover completely and are soon free from
infection.
2 Prevention of
further spread
The spread of infection can be controlled
by detecting infected horses early and isolating them until they are
free from infection. Shedding of S. equi usually ends rapidly
after recovery but may be intermittent.
To detect carrier horses, the Horserace
Betting Levy Board Code of Practice5 recommends taking 3
nasopharyngeal swabs at 5-7 day intervals over a 2-week period and
culturing the swabs for S.
equi. Three negative swabs indicate freedom from infection in
the great majority of cases but not all. Recovered cases may still
be carriers despite undergoing three negative swab tests.
Young animals are most susceptible to
infection and should be monitored
closely.
One approach to controlling an outbreak
is based on that used successfully by workers at the Animal Health
Trust7:
· Isolate
infected horses and those that had been in-conact with them.
Strict hygiene
measures should be employed: eg dedicated equipment for each
group, disinfection for
stable staff, thorough disinfection of stable and equipment. Stop
all movement of horses on and
off the premises.
·
Monitor horses that have been in
contact with sick animals or have shared the
same pasture. Check their temperatures twice daily. An increase in
temperature might indicate that the horse is about to develop the
disease. Antibiotic treatment is likely to be effective at this
stage.
·
Take
nasopharyngeal swabs from recovered cases and in-contact animals
on three occasions at weekly intervals. These samples should be
cultured for Streptococcus
equi. They can also be tested by PCR, for evidence of S equi M-protein, which is
more sensitive.
· Place
the horses in 2
groups according to results.
a
non-infectious :
(S equi is not
cultured, and at least the last PCR test is
negative.)
b
potentially infectious:
(S equi is
cultured or detected on PCR.)
·
Monitor
the infected group by examining the guttural pouches. Carry out
bacterial culture and PCR on samples from the guttural
pouches.
· Treat
any carriers:
a
flush the guttural pouches to remove any infecitious
discharges, and remove any
"chondroids".
b
give antibiotics (usually penicillin or potentiated
sulphonamides.)
Is there a vaccine? Over the
years there have been many attempts to produce a vaccine to protect
against strangles. No vaccine is currently available in the UK. Most
of the commercially available strangles vaccines available
worldwide contain
the M-protein from the
S equi cell surface-
either in an extracted form or as part of the inactivated whole
cell. These vaccines,
however, frequently produce adverse effects and induce poor immunity
against experimental infection.
Recent
research carried out in the Netherlands and Ireland in the search
for a safe and effective vaccine against strangles has produced
encouraging results.6,8 Dr Ton Jacobs and his colleagues tested
three different vaccines and three different vaccination routes in
Shetland ponies. Two weeks after the last vaccination the ponies
were challenged by intra-nasal application of a virulent strain
of S. equi. A live vaccine, produced from
genetically modified S
equi and administered by injection on the inside of the upper
lip appeared to be a
safe and effective method of vaccination.
Researchers
at the Animal Health Trust are currently working to identify
different sub-types of S.
equi using a variety of techniques including pulsed field gel
electrophoresis and DNA analysis. They hope that by correlating
their findings with informatin on the severity of the disease caused
by each subtype they may be able to locate the genes which are
responsible for severe disease. Hopefully this information will
allow them to develop an effective vaccine. (1)
|